Paul Trevino, et al. v. Davol Inc., et al.

Summary

Paul Trevino received Ventralex mesh as treatment for the hernia that arose after abdominal surgery. Trevino sues Davol Inc., a division of medical technology company C.R. Bard, claiming that the hernia mesh was defectively designed.

Attorneys for Trevino argue that Davol Inc. was aware of the risks to patients, yet continued to sell their mesh. This defective mesh, they claim, migrated to Trevino's bowel, causing him injuries and requiring surgical removal.

Representatives for Davol and Bard suggest Trevino's injuries were due to his original abdominal injury and other conditions. They highlight how doctors warned Trevino of the potential risks, and that the FDA has never recalled mesh from the market.

Playlists

Openings Setting Up CVN's Top 10 Most Impressive Plaintiff's Verdicts of 2022

Mesh Trial Closings